Historical salary details - Mr. Mark C. McKenna, Independent Director, NewAmsterdam Pharma Company NV
Mr. Mark C. McKenna is the Independent Director of NewAmsterdam Pharma Company NV. They also hold 4 other positions in Spyre Therapeutics Inc., Helix Acquisition Corp. II - Ordinary Shares - Class A, Apogee Therapeutics Inc. and Perceptive Capital Solutions Corp - Ordinary Shares - Class A.
Mr. Mark C. Mckenna
Independent Director
$ 687.5 K
Gross Remuneration
-
Current Company
NewAmsterdam Pharma Company NV
| YEAR | COMPANY | POSITION | SALARY | INCREMENT |
|---|---|---|---|---|
| 2024 | NewAmsterdam Pharma Company NV | Independent Director | 687.5 K | - |
| 2024 | Spyre Therapeutics Inc. | Independent Director | - | - |
| 2024 | Helix Acquisition Corp. II - Ordinary Shares - Class A | Independent Director | - | - |
| 2024 | Apogee Therapeutics Inc. | Chairman of the Board | - | - |
| 2024 | Perceptive Capital Solutions Corp - Ordinary Shares - Class A | Independent Director | - | - |
| 2023 | Apogee Therapeutics Inc. | Chairman of the Board | 972.9 K | - |
| 2023 | Spyre Therapeutics Inc. | Director | - | - |
| 2022 | Helix Acquisition Corp. II - Ordinary Shares - Class A | Independent Director | - | - |